有前途的选择性孕激素受体调节剂:女性避孕有什么新鲜事?
Anita Nelson1, Marit Pearlman Shapiro2
1Department of Obstetrics and Gynecology, Western University of Health Sciences, Pomona, CA, USA.
Expert opinion on investigational drugs
|October 29, 2024
概括
选择性孕激素受体调节剂 (SPRMs),如米费普里斯顿和乌利普里斯塔酸盐 (UPA),对药物流产和紧急避孕有效. 由于UPA,需要新的SPRM用于正在进行的无雌激素避孕,因为UPA需要新的SPRM.
科学领域:
- 生殖健康 生殖健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 选择性孕激素受体调节剂 (SPRMs),包括米费普里斯顿和乌利普里斯塔酸盐 (UPA),是药物流产和紧急避孕 (EC) 的已知治疗方法.
- 产科和妇科中SPRM的新兴应用包括偶发和持续使用,具有无雌激素避孕的显著潜力.
- 与UPA相关的罕见但严重的肝损伤的担忧影响了该领域的进一步研究和开发.
研究的目的:
- 审查SPRMs在妇女生殖健康中的生物物理影响和临床应用.
- 专注于米费普里斯顿和UPA在计划生育中的特殊作用.
- 提供SPRM行动机制的详细研究,特别是考虑到美国潜在的政治挑战.
主要方法:
- 关于SPRM生物物理影响和临床应用的文献综述.
- 对计划生育中的米费普里斯顿和UPA进行了集中分析.
- 详细描述SPRM的作用机制.
主要成果:
- 米菲普里斯顿和UPA是有效的一线选择,用于一次性应用.
- 没有不良出血模式的无雌激素持续避孕药的需求尚未得到满足.
- 目前对UPA的限制限制了其长期使用,凸显了替代SPRM的需要.
结论:
- SPRMs为妇女的生殖健康提供了有前途的途径,包括避孕和严重月经出血的管理.
- 开发具有改善安全性,特别是肝脏效应的新型SPRM至关重要.
- 未来的研究应该探索替代性SPRMs,以解决对安全有效的无雌激素的长期避孕选择的需求.
相关概念视频
Birth Control Methods
204
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
204
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
154
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
154
Hormonal Regulation of the Menstrual Cycle
308
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
308
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
362
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
362
Adrenergic Antagonists: ɑ and β-Receptor Blockers
407
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
407


